The effect of curcumin on type 1 diabetes

The effect of curcumin on glycemic control in children with type 1 diabetes

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181022041407N3

Enrollment

Registered

2023-06-17

Start date

2023-06-22

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin-dependent diabetes mellitus. Type 1 diabetes mellitus

Interventions

Intervention 1: Intervention group: Curcumin tablet daily (contains 500 mg Curcumin and 5 mg Piperine) made by Sami-Sabinsa Group Limited, for 90 days. Intervention 2: Control group: placebo (microcry

Eligibility

Sex/Gender

All

Age

7 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children aged 7-18 years Having type 1 diabetes Satisfaction for participation in research project

Exclusion criteria

Exclusion criteria: Patients with systemic diseases like renal or hepatic failure Oral intolerance of product Not satisfied with continuation of the study

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar (FBS). Timepoint: baseline and monthly for 3 months. Method of measurement: blood sample.;HbA1C. Timepoint: baseline, after 3 months. Method of measurement: blood sample.	—

Secondary

Measure	Time frame
Microalbuminuria. Timepoint: baseline and after 3 months. Method of measurement: urine analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Emadzadeh

Mashhad University of Medical Sciences

maryamemadzadeh@yahoo.com+98 51 3841 7403

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026